Cargando…
Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636406/ https://www.ncbi.nlm.nih.gov/pubmed/36333397 http://dx.doi.org/10.1038/s41598-022-23619-6 |
| _version_ | 1784824935247511552 |
|---|---|
| author | Gong, Jun Thomassian, Shant Kim, Sungjin Gresham, Gillian Moshayedi, Natalie Ye, Jason Y. Yang, Julianne C. Jacobs, Jonathan P. Lo, Simon Nissen, Nick Gaddam, Srinivas Tighiouart, Mourad Osipov, Arsen Hendifar, Andrew |
| author_facet | Gong, Jun Thomassian, Shant Kim, Sungjin Gresham, Gillian Moshayedi, Natalie Ye, Jason Y. Yang, Julianne C. Jacobs, Jonathan P. Lo, Simon Nissen, Nick Gaddam, Srinivas Tighiouart, Mourad Osipov, Arsen Hendifar, Andrew |
| author_sort | Gong, Jun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9636406 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96364062022-11-06 Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma Gong, Jun Thomassian, Shant Kim, Sungjin Gresham, Gillian Moshayedi, Natalie Ye, Jason Y. Yang, Julianne C. Jacobs, Jonathan P. Lo, Simon Nissen, Nick Gaddam, Srinivas Tighiouart, Mourad Osipov, Arsen Hendifar, Andrew Sci Rep Author Correction Nature Publishing Group UK 2022-11-04 /pmc/articles/PMC9636406/ /pubmed/36333397 http://dx.doi.org/10.1038/s41598-022-23619-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Gong, Jun Thomassian, Shant Kim, Sungjin Gresham, Gillian Moshayedi, Natalie Ye, Jason Y. Yang, Julianne C. Jacobs, Jonathan P. Lo, Simon Nissen, Nick Gaddam, Srinivas Tighiouart, Mourad Osipov, Arsen Hendifar, Andrew Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma |
| title | Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma |
| title_full | Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma |
| title_fullStr | Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma |
| title_full_unstemmed | Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma |
| title_short | Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma |
| title_sort | author correction: phase i trial of bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636406/ https://www.ncbi.nlm.nih.gov/pubmed/36333397 http://dx.doi.org/10.1038/s41598-022-23619-6 |
| work_keys_str_mv | AT gongjun authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT thomassianshant authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT kimsungjin authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT greshamgillian authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT moshayedinatalie authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT yejasony authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT yangjuliannec authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT jacobsjonathanp authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT losimon authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT nissennick authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT gaddamsrinivas authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT tighiouartmourad authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT osipovarsen authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma AT hendifarandrew authorcorrectionphaseitrialofbermekimabwithnanoliposomalirinotecanand5fuorouracilfolinicacidinadvancedpancreaticductaladenocarcinoma |